Status | Study |
Active, not recruiting |
Study Name: TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) Condition: Non-Small Cell Lung Cancer Lung Cancer Date: 2007-11-21 Interventions: Drug: Erlotinib 150 mg by mout |
Completed |
Study Name: AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib Condition: Advanced Renal Cell Carcinoma Date: 2007-04-26 Interventions: Drug: AMG 386 3 mg/kg or 10mg/ |
Completed |
Study Name: High-dose Bevacizumab in Advanced Renal Carcinoma Patients Condition: Renal Cancer Kidney Cancer Date: 2007-04-03 Interventions: Drug: Bevacizumab Bevacizumab Other Name: Avastin |
Completed |
Study Name: Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery Condition: Endometrial Cancer Date: 2007-03-15 Interventions: Radiation: Vaginal Brachytherapy |
Active, not recruiting |
Study Name: Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer Condition: Cervical Adenocarcinoma Cervical Adenosquamous Cell Carcinoma Date: 2006-12-27 Interventions: Radiation: fludeoxyglucose F 18 |
Active, not recruiting |
Study Name: Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer Condition: Endometrial Cancer Date: 2006-12-11 Interventions: Radiation: Radiation Therapy E |
Terminated |
Study Name: A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers Condition: Uterine Cancer Date: 2005-09-30 Interventions: Drug: Celecoxib |
Terminated |
Study Name: ATN-161 in Advanced Renal Cell Cancer Condition: Carcinoma, Renal Cell Date: 2005-08-17 Interventions: Drug: ATN-161 |
Completed |
Study Name: Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Cell Carcinoma Date: 2003-11-04 Interventions: Drug: temsirolimus Given IV |
Completed |
Study Name: ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer Condition: Non-Small-Cell Lung Carcinoma Renal Cell Carcinoma Pancrea Date: 2003-03-16 Interventions: Drug: ABR-217620 Starting dose: 0.5 mcg/kg; subsequent doses: individual, based on pre-treatment level o |